What are LQDA's recent SEC filings?
Liquidia Corporation filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting routine financial results and disclosing subsequent-event litigation settlements with United Therapeutics, Sandoz, and PBM.
View full filing details →Liquidia Corporation issued a press release announcing its financial results for the quarter ended September 30, 2026, and provided a corporate update. The company also updated its corporate presentation for use at healthcare conferences and investor meetings.
View full filing details →Liquidia Corporation filed a Form 8-K cover page with the SEC on October 14, 2026, reporting an event date of October 8, 2026. The filing contains only XBRL cover page data and no substantive disclosure of a specific corporate event.
View full filing details →Liquidia Corporation filed a Form 8-K cover page with the SEC on September 30, 2026. The filing contains only XBRL cover-page metadata and no substantive disclosure of a reportable event.
View full filing details →Liquidia Corporation filed a Form 8-K with the SEC on September 3, 2026, providing standard cover page information and indicating no material events were reported.
View full filing details →Has LQDA ever done a stock split?
No stock splits are recorded for LQDA.
What is LQDA's share float?
Get Real-Time LQDA Intelligence
SEPT X-Ray combines SEC filings with price targets, support/resistance levels, and smart money tracking — updated every 30 minutes.
Try SEPT X-Ray Free